Skip to main content
Cancers logoLink to Cancers
. 2025 Jul 30;17(15):2511. doi: 10.3390/cancers17152511

Correction: Chen et al. Multivariate Framework of Metabolism in Advanced Prostate Cancer Using Whole Abdominal and Pelvic Hyperpolarized 13C MRI—A Correlative Study with Clinical Outcomes. Cancers 2025, 17, 2211

Hsin-Yu Chen 1,*, Ivan de Kouchkovsky 2, Robert A Bok 1,2, Michael A Ohliger 1, Zhen J Wang 1, Daniel Gebrezgiabhier 1, Tanner Nickles 1, Lucas Carvajal 1, Jeremy W Gordon 1, Peder E Z Larson 1, John Kurhanewicz 1,2, Rahul Aggarwal 2, Daniel B Vigneron 1,2
PMCID: PMC12346704  PMID: 40805300

Error in Figure

In the original publication [1], there was a mistake in Figures 2 and 5 as published. Figures with an old, obsolete kPL unit (s−1) were erroneously uploaded during editing and proofreading. These figures are now corrected and have been replaced with kPL unit ks−1, which is the preferable style. The corrected Figure 2 and Figure 5 appear below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.

Figure 2.

Figure 2

HP multiparametric features of metabolism (MFM) kPL,median was selected and applied to univariate Cox proportional hazards model. (A) Kaplan–Meier analysis revealed substantially longer PFS and OS in patients with kPL,median ≤ 17 ks−1 (median PFS: 11.2 vs. 0.5 months; median OS: NR vs. 18.4 months). (B) Example cases illustrating metastatic prostate cancer patients with kPL,median higher and lower than the dichotomized cutoff value of 17. The patient on the left had high-volume liver metastases with kPL,median = 24.8, whereas on the right had low or undetectable kPL,median across the osseous pelvic metastases. Images shown were kPL heatmaps overlaid on 1H T1-FSPGR references. * p < 0.05, ** p < 0.01.

Figure 5.

Figure 5

Hypothesis-generating multivariate survival analyses using (A) metabolic prognostic score (MPS) derived from multivariate Cox proportional hazards model, adjusted for patient age. (B) MPS was significantly associated with both PFS (p < 0.002) and OS (p < 0.05), with longer median PFS (NR vs. 2.4 months) and OS (NR vs. 18.4 months) for lower-MPS vs. higher-MPS patients, dichotomized by the cohort median MPS = −0.581. * p < 0.05, ** p < 0.01.

Footnotes

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Reference

  • 1.Chen H.-Y., de Kouchkovsky I., Bok R.A., Ohliger M.A., Wang Z.J., Gebrezgiabhier D., Nickles T., Carvajal L., Gordon J.W., Larson P.E.Z., et al. Multivariate Framework of Metabolism in Advanced Prostate Cancer Using Whole Abdominal and Pelvic Hyperpolarized 13C MRI—A Correlative Study with Clinical Outcomes. Cancers. 2025;17:2211. doi: 10.3390/cancers17132211. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cancers are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES